Top news
What India's COVID-19 crisis means for Africa | Brookings
If you got the Johnson & Johnson vaccine, do you need another dose?
By Jane Weaver & Akshay Syal
Two doses of Pfizer, AstraZeneca shots effective against Delta variant: study
By barbara lewis & Alistair Smout
All coverage
Pfizer-BioNTech to start producing Covid-19 vaccines in South Africa in 2022
By David McKenzie & Jeevan Ravindran
The Delta Variant, Covid-19 Symptoms and Vaccine Efficacy: What to Know
By Jared S. Hopkins & Robbie Whelan
J.&J. Vaccine May Be Less Effective Against Delta, Study Suggests (Published 2021)
By Apoorva Mandavilli
Israel says Pfizer Covid vaccine is just 39% effective as delta spreads, but still prevents severe illness
By Berkeley Lovelace & Berkeley Lovelace Jr.
Africa demands local production of COVID vaccines
By Duncan Miriri & George Obulutsa
South African firm to help make Pfizer/BioNTech COVID vaccine
By Michael Erman, Wendell Roelf & Alexander Winning
J&J forecasts $2.5 bln in 2021 COVID-19 vaccine sales, sets lower production target
By Manas Mishra & Carl O'Donnell